Mediterranean diet and the Spanish paradox. A hypothesis

Medical Hypotheses

Volumn 80, Issue 2, 2013, Pages 150-155

  Soriguer, Federico ^a,b,c   García Escobar, Eva ^a,b,c   Morcillo, Sonsoles ^b   García Fuentes, Eduardo ^a,c   Rodríguez de Fonseca, Fernando ^a   Olveira, Gabriel ^a,b,c   Rojo Martínez, Gemma ^a,b,c  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Instituto de Salud Carlos III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COCONUT OIL; CYTOKINE; LIPID; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID; STEAROYL COENZYME A; SUNFLOWER OIL;

ARTERIOSCLEROSIS; ARTICLE; BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CYTOKINE RELEASE; DIABETES MELLITUS; DIETARY INTAKE; ENZYME ACTIVITY; FATTY LIVER; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPOGENESIS; MEDITERRANEAN DIET; METABOLIC SYNDROME X; MORBIDITY; NONHUMAN; OBESITY; OXIDATIVE STRESS; PROTEIN EXPRESSION; SPAIN;

ADIPOSITY; CARDIOVASCULAR DISEASES; DIET, MEDITERRANEAN; HUMANS; LIPIDS; MODELS, BIOLOGICAL; PLANT OILS; PREVALENCE; RISK FACTORS; SPAIN; STEAROYL-COA DESATURASE;

EID: 84872346243     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.11.015     Document Type: Article

References (63)

1. Huffman M.D., Bhatnagar D. Novel treatments for cardiovascular disease prevention. Cardiovasc Ther 2012, 30(5):257-263.
2. Gersh B.J., Sliwa K., Mayosi B.M., Yusuf S. Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications. Eur Heart J 2010, 31:642-648.
3. Masia R., Pena A., Marrugat J., et al. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR investigators. J Epidemiol Community Health 1998, 52:707-715.
4. Medrano M.J., Cerrato E., Boix R., Delgado-Rodriguez M. Cardiovascular risk factors in Spanish population: metaanalysis of cross-sectional studies. Med Clin (Barc) 2005, 124:606-612.
5. Villar Alvarez F., Banegas Banegas J.R., Rodriguez Artalejo F., del Rey Calero J. Cardiovascular mortality in Spain and its autonomous communities (1975-1992). Med Clin (Barc) 1998, 110:321-327.
6. Serra-Majem L., Ribas L., Tresserras R., Ngo J., Salleras L. How could changes in diet explain changes in coronary heart disease mortality in Spain? The Spanish paradox. Am J Clin Nutr 1995, 61:1351S-1359S.
7. Soriguer F., Almaraz M.C., Garcia-Almeida J.M., et al. Intake and home use of olive oil or mixed oils in relation to healthy lifestyles in a Mediterranean population. Findings from the prospective Pizarra study. Br J Nutr 2010, 103:114-122.
8. Soriguer F., Rojo-Martinez G., de Fonseca F.R., Garcia-Escobar E., Garcia Fuentes E., Olveira G. Obesity and the metabolic syndrome in Mediterranean countries: a hypothesis related to olive oil. Mol Nutr Food Res 2007, 51:1260-1267.
9. Willett W.C., Sacks F., Trichopoulou A., et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995, 61:1402S-1406S.
10. Keys A., Aravanis C., Blackburn H.W., et al. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand Suppl 1966, 460:1-392.
11. Kimura N., Keys A. Coronary heart disease in seven countries. X. Rural southern Japan. Circulation 1970, 41:I101-I112.
12. Trichopoulou A., Costacou T., Bamia C., Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003, 348:2599-2608.
13. de Lorgeril M., Renaud S., Mamelle N., et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994, 343:1454-1459.
14. Singh R.B., Dubnov G., Niaz M.A., et al. Effect of an Indo-Mediterranean diet on progression of coronary artery disease in high risk patients (Indo-Mediterranean Diet Heart Study): a randomised single-blind trial. Lancet 2002, 360:1455-1461.
15. Perez-Jimenez F., Alvarez de Cienfuegos G., Badimon L., et al. International conference on the healthy effect of virgin olive oil. Eur J Clin Invest 2005, 35:421-424.
16. Lopez-Miranda J., Perez-Jimenez F., Ros E., et al. Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaen and Cordoba (Spain) 2008. Nutr Metab Cardiovasc Dis 2010, 20:284-294.
17. Ntambi J.M. The regulation of stearoyl-CoA desaturase (SCD). Prog Lipid Res 1995, 34:139-150.
18. Soriguer F.J., Tinahones F.J., Monzon A., et al. Varying incorporation of fatty acids into phospholipids from muscle, adipose and pancreatic exocrine tissues and thymocytes in adult rats fed with diets rich in different fatty acids. Eur J Epidemiol 2000, 16:585-594.
19. Roche E., Buteau J., Aniento I., Reig J.A., Soria B., Prentki M. Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1. Diabetes 1999, 48:2007-2014.
20. Miyazaki M., Kim H.J., Man W.C., Ntambi J.M. Oleoyl-CoA is the major de novo product of stearoyl-CoA desaturase 1 gene isoform and substrate for the biosynthesis of the Harderian gland 1-alkyl-2,3-diacylglycerol. J Biol Chem 2001, 276:39455-39461.
21. Dobrzyn A., Ntambi J.M. Stearoyl-CoA desaturase as a new drug target for obesity treatment. Obes Rev 2005, 6:169-174.
22. Merino D.M., Ma D.W., Mutch D.M. Genetic variation in lipid desaturases and its impact on the development of human disease. Lipids Health Dis 2010, 9:63.
23. Ntambi J.M., Miyazaki M., Dobrzyn A. Regulation of stearoyl-CoA desaturase expression. Lipids 2004, 39:1061-1065.
24. Sampath H., Miyazaki M., Dobrzyn A., Ntambi J.M. Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem 2007, 282:2483-2493.
25. Cohen P., Miyazaki M., Socci N.D., et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002, 297:240-243.
26. Ntambi J.M., Miyazaki M., Stoehr J.P., et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 2002, 99:11482-11486.
27. Dobrzyn P., Dobrzyn A., Miyazaki M., et al. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci U S A 2004, 101:6409-6414.
28. Lee S.H., Dobrzyn A., Dobrzyn P., Rahman S.M., Miyazaki M., Ntambi J.M. Lack of stearoyl-CoA desaturase 1 upregulates basal thermogenesis but causes hypothermia in a cold environment. J Lipid Res 2004, 45:1674-1682.
29. Araya J., Rodrigo R., Videla L.A., et al. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond) 2004, 106:635-643.
30. Miyazaki M., Kim Y.C., Gray-Keller M.P., Attie A.D., Ntambi J.M. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem 2000, 275:30132-30138.
31. Miyazaki M., Kim Y.C., Ntambi J.M. A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J Lipid Res 2001, 42:1018-1024.
32. Miyazaki M., Dobrzyn A., Sampath H., et al. Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha. J Biol Chem 2004, 279:35017-35024.
33. Serrano A., Del Arco I., Pavón J., Macías M., Perez-Valero V., Rodríguez de Fonseca F. The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats. Neuropharmacology 2008, 54(1):226-234.
34. Nan Y.M., Wu W.J., Fu N., et al. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. Scand J Gastroenterol 2009, 44:1121-1131.
35. Bjermo H., Riserus U. Role of hepatic desaturases in obesity-related metabolic disorders. Curr Opin Clin Nutr Metab Care 2010, 13:703-708.
36. Buhman K.F., Accad M., Farese R.V. Mammalian acyl-CoA:cholesterol acyltransferases. Biochim Biophys Acta 2000, 1529:142-154.
37. Attie A.D., Krauss R.M., Gray-Keller M.P., et al. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res 2002, 43:1899-1907.
38. Rahman S.M., Dobrzyn A., Dobrzyn P., Lee S.H., Miyazaki M., Ntambi J.M. Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle. Proc Natl Acad Sci U S A 2003, 100:11110-11115.
39. Unger R.H. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 2003, 14:398-403.
40. Dobrzyn A., Dobrzyn P., Lee S.H., et al. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. Am J Physiol Endocrinol Metab 2005, 288:E599-E607.
41. Brown J.M., Chung S., Sawyer J.K., et al. Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis. Circulation 2008, 118:1467-1475.
42. Fessler M.B., Rudel L.L., Brown J.M. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol 2009, 20:379-385.
43. Weatherill A.R., Lee J.Y., Zhao L., Lemay D.G., Youn H.S., Hwang D.H. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol 2005, 174:5390-5397.
44. Brown J.M., Chung S., Sawyer J.K., et al. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2010, 30:24-30.
45. Flowers M.T., Ntambi J.M. Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism. Curr Opin Lipidol 2008, 19:248-256.
46. Chen C., Shah Y.M., Morimura K., et al. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab 2008, 7:135-147.
47. Keys A., Taylor H.L., Blackburn H., Brozek J., Anderson J.T., Simonson E. Coronary heart disease among minnesota business and professional men followed fifteen years. Circulation 1963, 28:381-395.
48. Burr G.O., Burr M.M. On the nature and role of the fatty acids essential in nutrition. J Biol Chem 1930, 86:587.
49. Ailhaud G., Massiera F., Weill P., Legrand P., Alessandri J.M., Guesnet P. CAMP-dependent signaling regulates the adipogenic effect of n-6 polyunsaturated fatty acids. J Biol Chem 2008, 283(11):7196-7205.
50. Spector A.A., Hoak J.C., Fry G.L., Stoll L.L., Tanke C.T., Kaduce T.L. Essential fatty acid availability and prostacyclin production by cultured human endothelial cells. Prog Lipid Res 1981, 20:471-477.
51. Soriguer F., Moreno F., Rojo-Martinez G., et al. Monounsaturated n-9 fatty acids and adipocyte lipolysis in rats. Br J Nutr 2003, 90:1015-1022.
52. Ntambi J.M., Bene H. Polyunsaturated fatty acid regulation of gene expression. J Mol Neurosci 2001, 16:273-278. [discussion 279-84].
53. Warensjo E., Riserus U., Gustafsson I.B., Mohsen R., Cederholm T., Vessby B. Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention. Nutr Metab Cardiovasc Dis 2008, 18:683-690.
54. Ntambi J.M. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J Lipid Res 1999, 40:1549-1558.
55. Velliquette R.A., Gillies P.J., Kris-Etherton P.M., Green J.W., Zhao G., Vanden Heuvel J.P. Regulation of human stearoyl-CoA desaturase by omega-3 and omega-6 fatty acids: implications for the dietary management of elevated serum triglycerides. J Clin Lipidol 2009, 3:281-288.
56. Vassaux G., Gaillard D., Ailhaud G., Negrel R. Prostacyclin is a specific effector of adipose cell differentiation. Its dual role as a cAMP- and Ca(2+)-elevating agent. J Biol Chem 1992, 267:11092-11097.
57. Bellenger J., Bellenger S., Clement L., et al. A new hypotensive polyunsaturated fatty acid dietary combination regulates oleic acid accumulation by suppression of stearoyl CoA desaturase 1 gene expression in the SHR model of genetic hypertension. FASEB J 2004, 18:773-775.
58. Haro-Mora J.J., Garcia-Escobar E., Porras N., et al. Children whose diet contained olive oil had a lower likelihood of increasing their BMI Z-score over one year. Eur J Endocrinol 2011, 165(3):435-439.
59. Jiang Z., Michal J.J., Tobey D.J., Daniels T.F., Rule D.C., Macneil M.D. Significant associations of stearoyl-CoA desaturase (SCD1) gene with fat deposition and composition in skeletal muscle. Int J Biol Sci 2008, 4:345-351.
60. Garcia-Escobar E., Rodriguez-Pacheco F., Garcia-Serrano S., et al. Nutritional regulation of interleukin-6 release from adipocytes. Int J Obes (Lond) 2010, 34:1328-1332.
61. Ailhaud G., Guesnet P. Fatty acid composition of fats is an early determinant of childhood obesity: a short review and an opinion. Obes Rev 2004, 5:21-26.
62. Warensjo E., Ingelsson E., Lundmark P., et al. Polymorphisms in the SCD1 gene: associations with body fat distribution and insulin sensitivity. Obesity (Silver Spring) 2007, 15:1732-1740.
63. Barton L., Kott T., Bures D., Rehak D., Zahradkova R., Kottova B. The polymorphisms of stearoyl-CoA desaturase (SCD1) and sterol regulatory element binding protein-1 (SREBP-1) genes and their association with the fatty acid profile of muscle and subcutaneous fat in Fleckvieh bulls. Meat Sci 2010, 85:15-20.